Niraparib Demonstrates Prolonged PFS In Phase III Trial, Achieving Primary Endpoint August 04, 2016Vol.39 No.07
Kyprolis, Lenalidomide and Dexamethasone Combination Improves PFS, OS in Phase III July 01, 2016Vol.39 No.06
Tafinlar-Mekinist Combination Shows Significant Benefit in BRAF V600E/K Population June 30, 2016Vol.39 No.06
Combination of Surgery and Standard Therapy Increases Survival in Stage IV, Study Says June 30, 2016Vol.39 No.06